Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest

Carcinogenesis

Volumn 25, Issue 10, 2004, Pages 1945-1952

  Cheong, E ^a,b   Ivory, K ^b   Doleman, J ^b   Parker, M L ^b   Rhodes, M ^a   Johnson, Ian ^b  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

^b INSTITUTE OF FOOD RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE ORANGE; CYCLOOXYGENASE 2 INHIBITOR; ETHIDIUM BROMIDE; FLAVONOID; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NIMESULIDE; PROSTAGLANDIN E2; QUERCETIN; RESVERATROL;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; BIOLOGICAL MODEL; CANCER CELL; CANCER CELL CULTURE; CELL ADHESION; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SELECTIVITY; ENZYME INHIBITION; ESOPHAGUS CARCINOMA; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; FOOD; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERPHASE; MITOSIS INHIBITION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; QUANTITATIVE ANALYSIS; STAINING; STATISTICAL SIGNIFICANCE; TIME;

ADENOCARCINOMA; APOPTOSIS; CELL CYCLE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; ESOPHAGEAL NEOPLASMS; HUMANS; ISOENZYMES; MEMBRANE PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; TUMOR CELLS, CULTURED;

EID: 6444232693     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh184     Document Type: Article

References (49)

1. Blot,W.J., Devesa,S.S., Kneller,R.W. and Fraumeni,J.F.,Jr (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia. J. Am. Med. Assoc., 265, 1287-1289.
2. Pera,M., Cameron,A.J., Trastek,V.F., Carpenter,H.A. and Zinsmeister,A.R. (1993) Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology, 104 510-513.
3. Prach,A.T., MacDonald,T.A., Hopwood,D.A. and Johnston,D.A. (1997) Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet, 350, 933.
4. Bollschweiler,E., Wolfgarten,E., Gutschow,C. and Holscher,A.H. (2001) Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer, 92, 549-555.
5. Devesa,S.S., Blot,W.J. and Fraumeni,J.F.,Jr (1998) Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer, 83, 2049-2053.
6. Botterweck,A.A., Schouten,L.J., Volovics,A., Dorant,E. and van Den Brandt,P.A. (2000) Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int. J. Epidemiol., 29, 645-654.
7. Blot,W.J. and McLaughlin,J.K. (1999) The changing epidemiology of esophageal cancer. Semin. Oncol., 26, 2-8.
8. Corley,D.A., Kerlikowske,K., Verma,R. and Buffler,P. (2003) Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology, 124, 47-56.
9. Prescott,S.M. and White,R.L. (1996) Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87 783-786.
10. Mitchell,J.A., Larkin,S. and Williams,T.J. (1995) Cyclooxygenase-2: regulation and relevance in inflammation. Biochem. Pharmacol., 50, 1535-1542.
11. Oshima,M., Dinchuk,J.E., Kargman,S.L., Oshima,H., Hancock,B., Kwong,E., Trzaskos,J.M., Evans,J.F. and Taketo,M.M. (1996) Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-809.
12. Williams,C.S., Mann,M. and DuBois,R.N. (1999) The role of cyclooxygenases in inflammation, cancer and development. Oncogene, 18, 7908-7916.
13. Buttar,N.S., Wang,K.K., Leontovich,O., Westcott,J.Y., Pacifico,R.J. Anderson,M.A., Krishnadath,K.K., Lutzke,L.S. and Burgart,L.J. (2002) Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 122, 1101-1112.
14. Hawkey,C.J. and Rampton,D.S. (1985) Prostaglandins and the gastrointestinal mucosa: are they important in its function, disease, or treatment? Gastroenterology, 89, 1162-1188.
15. Tsujii,M., Kawano,S. and DuBois,R.N. (1997) Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc. Natl Acad. Sci. USA, 94, 3336-3340.
16. Shirvani,V.N., Ouatu-Lascar,R., Kaur,B.S., Omary,M.B. and Triadafilopoulos,G. (2000) Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology, 118, 487-496.
17. Cheong,E., Igali,L., Harvey,I., Mole,M., Lund,E., Johnson,I.T. and Rhodes,M. (2003) Cyclo-oxygenase-2 expression in Barrett's oesophageal carcinogenesis: an immunohistochemical study. Aliment. Pharmacol. Ther., 17, 379-386.
18. Zimmermann,K.C., Sarbia,M., Weber,A.A., Borchard,F., Gabbert,H.E. and Schror,K. (1999) Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res., 59, 198-204.
19. Formica,J.V. and Regelson,W. (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol., 33, 1061-1080.
20. Chen,H., Ward,M.H., Graubard,B.I., Heineman,E.F., Markin,R.M., Potischman,N.A., Russel],R.M., Weisenburger,D.D. and Tucker,K.L. (2002) Dietary patterns and adenocarcinoma of the esophagus and distal stomach. Am. J. Clin. Nutr., 75, 137-144.
21. Gao,Y.T., McLaughlin,J.K., Blot,W.J., Ji,B.T., Dai,Q. and Fraumeni,J.F.,Jr (1994) Reduced risk of esophageal cancer associated with green tea consumption. J. Natl Cancer Inst., 86, 855-858.
22. Sun,C.L., Yuan,J.M., Lee,M.J., Yang,C.S., Gao,Y.T., Ross,R.K. and Yu,M.C. (2002) Urinary tea polyphenols in relation to gastric and esophageal cancers: a prospective study of men in Shanghai, China. Carcinogenesis, 23, 1497-1503.
23. Mutoh,M., Takahashi,M., Fukuda,K., Komatsu,H., Enya,T., Matsushima-Hibiya,Y., Mutoh,H., Sugimura,T. and Wakabayashi,K. (2000) Suppression by flavonoids of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells: structure-activity relationship. Jpn. J. Cancer Res., 91, 686-691.
24. Hollman,P.C. and Katan,M.B. (1997) Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother., 51, 305-310.
25. Rockett,J.C., Larkin,K., Darnton,S.J., Morris,A.G. and Matthews,H.R. (1997) Five newly established oesophageal carcinoma cell lines: phenotypic and immunological characterization. Br. J. Cancer 75, 258-263.
26. Mutoh,M., Takahashi,M., Fukuda,K., Matsushima-Hibiya,Y., Mutoh,H., Sugimura,T. and Wakabayashi,K. (2000) Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis, 21, 959-963.
27. Hague,A., Manning,A.M., Hanlon,K.A., Huschtscha,L.I., Hart,D. and Paraskeva,C. (1993) Sodium butyrate induces apoptosis in human colonic tumour cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55, 498-505.
28. Gregory,C.D., Dive,C., Henderson,S., Smith,C.A., Williams,G.T., Gordon,J. and Richinson,A.B. (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature, 349, 612-614.
29. Hague,A., Manning,A., Hanlon,K., Huschtscha,L., Hart,D. and Paraskeva,C. (1993) Sodium butyrate induces apoptosis in human colonic tumor cell lines in a p53-independent pathway: implications for the possible role of dietary fibre in the prevention of large-bowel cancer. Int. J. Cancer, 55, 498-505.
30. Riboli,E. and Norat,T. (2003) Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am. J. Clin. Nutr., 78, 559S-569S.
31. Gee,J.M., Hara,H. and Johnson,I.T. (2002) Suppression of intestinal crypt cell proliferation and aberrant crypt foci by dietary quercetin in rats. Nutr. Cancer, 43, 193-201.
32. Wattenberg,L.W. (1992) Inhibition of carcinogenesis by minor dietary constituents. Cancer Res., 52, 2085s-2091s.
33. Zhang,F., Subbaramaiah,K., Altorki,N. and Dannenberg,A.J. (1998) Dihydroxy bile acids activate the transcription of cyclooxygenase-2. J. Biol. Chem., 273, 2424-2428.
34. Zhang,F., Altorki,N.K., Wu,Y.C., Soslow,R.A., Subbaramaiah,K. and Dannenberg,A.J. (2001) Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology, 121, 1391-1399.
35. Kaur,B.S., Khamnehei,N., Iravani,M., Namburu,S.S., Lin,O. and Triadafilopoulos,G. (2002) Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus. Gastroenterology, 123, 60-67.
36. Baumann,J., von Bruchhausen,F. and Wurm,G. (1980) Flavonoids and related compounds as inhibition of arachidonic acid peroxidation. Prostaglandins, 20, 627-639.
37. Lee,T.P., Matteliano,M.L. and Middleton,E.,Jr (1982) Effect of quercetin on human polymorphonuclear leukocyte lysosomal enzyme release and phospholipid metabolism. Life Sci., 31, 2765-2774.
38. Day,A.J., Mellon,F., Barron,D., Sarrazin,G., Morgan,M.R. and Williamson,G. (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic. Res. 35, 941-952.
39. de Pascual-Teresa,S., Johnston,K.L., DuPont,M.S., O'Leary,K.A., Needs,P.W., Morgan,L.M., Clifford,M.N., Bao,Y. and Williamson,G. (2004) Quercetin metabolites downregulate cyclooxygenase-2 transcription in human lymphocytes ex vivo but not in vivo. J. Nutr., 134, 552-557.
40. Agullo,G., Gamet-Payrastre,L., Manenti,S., Viala,C., Remesy,C., Chap,H. and Payrastre,B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem. Pharmacol., 53, 1649-1657.
41. Blanco,A., Habib,A., Levy-Toledano,S. and Maclouf,J. (1995) Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells. Biochem. J., 312, 419-423.
42. Ferriola,P.C., Cody,V. and Middleton,E.,Jr (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem. Pharmacol., 38, 1617-1624.
43. Barnekow,A. and Gessler,M. (1986) Activation of the pp60c-src kinase during differentiation of monomyelocytic cells in vitro. EMBO J., 5, 701-705.
44. Subbaramaiah,K., Chung,W.J., Michaluart,P., Telang,N., Tanabe,T., Inoue,H., Jang,M., Pezzuto,J.M. and Dannenberg,A.J. (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem. 273, 21875-21882.
45. Grosch,S., Tegeder,I., Niederberger,E., Brautigam,L. and Geisslinger,G. (2001) COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib. FASEB J., 15, 2742-2744.
46. Niederberger,E., Tegeder,I., Vetter,G., Schmidtko,A., Schmidt,H., Euchenhofer,C., Brautigam,L., Grosch,S. and Geisslinger,G. (2001) Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-kappaB. FASEB J., 15, 1622-1624.
47. Han,S.Y., Choung,S.Y., Paik,I.S., Kang,H.J., Choi,Y.H., Kim,S.J. and Lee,M.O. (2000) Activation of NF-kappaB determines the sensitivity of human colon cancer cells to TNFalpha-induced apoptosis. Biol. Pharm. Bull., 23, 420-426.
48. Hsu,A.L., Ching,T.T., Wang,D.S., Song,X., Rangnekar,V.M. and Chen,C.S. (2000) The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2. J. Biol. Chem., 275, 11397-11403.
49. Tseng,W.W., Deganutti,A., Chen,M.N., Saxton,R.E. and Liu,C.D. (2002) Selective cyclooxygenase-2 inhibitor rofecoxib (Vioxx) induces expression of cell cycle arrest genes and slows tumor growth in human pancreatic cancer. J. Gastrointest. Surg., 6, 838-843.